Literature DB >> 19462349

[Flow cytometric basophils activation test as a method of allergy diagnosis].

Olga Potapińska1, Urszula Demkow, Maria Wasik.   

Abstract

For several years the incidences of allergic diseases and anaphylactic reactions have been increasing dramatically. Classical method of allergy diagnosis - skin prick test in some situations can provoke life-threatening reactions. Detection of allergen-induced basophil activation by flow cytometry has been shown to be a useful tool for allergy diagnosis in those patients. CD 63 and CD203c have recently been demonstrated as a specific activation markers of basophils that are rapidly up-regulated after allergen challenge in sensitized patients. Although flow-cytometry methods are quite sophisticated and expensive, it could be a good alternative in patients at risk of severe anaphylactic reactions or with contradictory test results.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19462349

Source DB:  PubMed          Journal:  Pneumonol Alergol Pol        ISSN: 0867-7077


  4 in total

1.  Monitoring of CD63% in basophil activation test and suggested new parameters for allergy diagnosis.

Authors:  Salvatore Chirumbolo
Journal:  Inflamm Res       Date:  2011-12-29       Impact factor: 4.575

2.  Vascular endothelial growth factor-activated basophils in asthmatics.

Authors:  Krzysztof Gomułka; Jerzy Liebhart; Andrzej Lange; Wojciech Mêdrala
Journal:  Postepy Dermatol Alergol       Date:  2020-06-25       Impact factor: 1.837

Review 3.  Drugs as important factors causing allergies.

Authors:  Wioletta A Żukiewicz-Sobczak; Paula Wróblewska; Piotr Adamczuk; Jacek Zwoliński; Anna Oniszczuk; Paulina Wojtyła-Buciora; Wojciech Silny
Journal:  Postepy Dermatol Alergol       Date:  2015-10-29       Impact factor: 1.837

4.  Basophil activation test based on the expression of CD203c in the diagnostics of cow milk allergy in children.

Authors:  Olga Ciepiela; J Zwiazek; A Zawadzka-Krajewska; I Kotula; M Kulus; U Demkow
Journal:  Eur J Med Res       Date:  2010-11-04       Impact factor: 2.175

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.